+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • February 2025
  • 225 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
From
From
From
Rare Kidney Diseases Market Report 2025 - Product Thumbnail Image

Rare Kidney Diseases Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Kidney Transplant Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Synthetic Biology Market Report 2024-2034 - Product Thumbnail Image

Synthetic Biology Market Report 2024-2034

  • Report
  • July 2024
  • 402 Pages
  • Global
From
Licensing Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1250 Pages
  • Global
From
Loading Indicator